BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 8603767)

  • 1. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
    Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
    Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
    Lewis GF; Vranic M; Harley P; Giacca A
    Diabetes; 1997 Jul; 46(7):1111-9. PubMed ID: 9200644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
    Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
    J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans.
    Lewis GF; Vranic M; Giacca A
    Am J Physiol; 1997 Mar; 272(3 Pt 1):E371-8. PubMed ID: 9124541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans.
    Lewis GF; Vranic M; Giacca A
    Am J Physiol; 1998 Jul; 275(1):E177-86. PubMed ID: 9688888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Igawa K; Chu CA; Balcom JH; Neal DW; Cherrington AD
    Am J Physiol; 1999 Apr; 276(4):E806-13. PubMed ID: 10198319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans.
    Lewis GF; Carpentier A; Bilinski D; Giacca A; Vranic M
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1037-46. PubMed ID: 10084592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
    Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
    Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
    Sindelar DK; Chu CA; Venson P; Donahue EP; Neal DW; Cherrington AD
    Diabetes; 1998 Apr; 47(4):523-9. PubMed ID: 9568682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
    Rebrin K; Steil GM; Getty L; Bergman RN
    Diabetes; 1995 Sep; 44(9):1038-45. PubMed ID: 7657026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic insulin resistance after pancreas transplantation in type I diabetes.
    Rooney DP; Robertson RP
    Diabetes; 1996 Feb; 45(2):134-8. PubMed ID: 8549855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
    Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia.
    Barrou Z; Seaquist ER; Robertson RP
    Diabetes; 1994 May; 43(5):661-6. PubMed ID: 8168643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogs.
    Gregory JM; Kraft G; Scott MF; Neal DW; Farmer B; Smith MS; Hastings JR; Madsen P; Kjeldsen TB; Hostrup S; Brand CL; Fledelius C; Nishimura E; Cherrington AD
    Diabetes Obes Metab; 2019 Oct; 21(10):2294-2304. PubMed ID: 31183936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
    Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L
    Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.